tangotx.com (TNGX): Narxning prognoz qilingan daromadga nisbati

TNGX (Tango Therapeutics Inc) - kompaniyaning tovar belgisi

Kutilayotgan P/S ko'rsatkichi Tango Therapeutics (TNGX) kompaniyasining baholash dinamikasini aks ettiradi, bunda indikator darajasi 71.20 ni tashkil etadi. Tango Therapeutics (TNGX) qat'iy patent himoyasi ostida sintetik letallik printsipiga asoslangan maqsadli dori vositalarini ishlab chiqadi. Yuqori R&D xarajatlari mahsulotlar tijoratlashtirilgunga qadar operatsion foydani vaqtincha to'sib turadi. Biznes muvaffaqiyati genetik tadqiqotlar, inson kapitali va tartibga soluvchi organlarning tasdig'iga bog'liq.

TNGX Tango Therapeutics Inc: Bozor kapitallashuvining kelajakdagi daromadga nisbati 04.07.2022 - 10.11.2026 oraligʻida

Tango Therapeutics Corp (TNGX) kompaniyasining tahliliy kesimlari

Kompaniyaning jamlanma tahlili:Tango Therapeutics, Inc. TNGX
Tango Therapeutics Corp tomonidan chiqariladigan mahsulotlar

Oldingi P/S koeffitsiyenti biznes qiymatini kutilayotgan tushumga nisbatan belgilaydi va kelajakdagi o'sish sur'atlari uchun to'langan premiumni baholash imkonini beradi. Ushbu metrikaning ekstremal nuqtalarini kuzatish institutsional ishtirokchilarga kapital risklarini minimallashtirishga yordam beradi. GURU.Markets platformasida biznesning oldingi P/S koeffitsiyentini tahlil qilish orqali investor kompaniyaning salohiyatiga bozorning joriy bahosini ko'rishi mumkin. Tango Therapeutics (TNGX) uchun ushbu ko'rsatkich juda muhimdir, chunki klinik sinovlar xarajatlari tufayli barqaror pul oqimlarining yo'qligi baholashni spekulyativ qiladi.

Raqobatchilar tahlili

ImmunityBio - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Immunocore Holdings IMCR|JANX - Narxning prognoz qilingan daromadga nisbati|RCUS (Arcus Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Zymeworks Inc. (ZYME) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati iovance.com (IOVA)|Forvard narx/daromad multiplikatori IMTX|XNCR - Prognoz narxning daromadga nisbati|Forvard narx/daromad multiplikatori CMPX (Compass Bio)|Narxning kutilayotgan daromadga nisbati REPL|Forvard P/S multiplikatori LYEL (Lyell Immunopharma)|Sotuvga nisbatan forvard narx IPHA|Pyxis - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Compugen Ltd.|IO Biotech Corp (IOBT) - Narxning prognoz qilingan daromadga nisbati|Sutro Biopharma, Inc - Sotuvga nisbatan forvard narx|INKT (MiNK Therapeutics, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Werewolf|Narxning prognoz qilingan daromadga nisbati Immix Biopharma, Inc. (IMMX)|ALXO: Kelajakdagi narxning daromadga nisbati|Cue Biopharma, Inc. - Forvard narx/daromad multiplikatori|PDS Biotech (PDSB) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|SONN: Forvard narx/daromad multiplikatori|MAIABiotech.com - Narxning kutilayotgan daromadga nisbati|LIMN: Forvard P/S multiplikatori|LAVA Therapeutics (LVTX) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati NextCure Corp|Kapitalizatsiyaning prognoz qilingan daromadga nisbati LPTX (Leap Tx)|Forvard P/S multiplikatori INTS|senseibio.com (SNSE) - Prognoz narxning daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Theriva Biologics TOVX|Gritstone bio Inc. (GRTS) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|KA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx NEXI (NexImmune Corporation)|TSBX (turnstonebio.com) - Forvard narx/daromad multiplikatori|VCNX: Narxning kutilayotgan daromadga nisbati|HARP (Harpoon Therapeutics, Inc.) - Forvard P/S multiplikatori